11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

By J. Tiihonen, J. Lönnqvist, K. Wahlbeck, T. Klaukka, L. Niskanen, Antti J. Tanskanen, J. Haukka. The Lancet, 2009

1,033 citations recorded by the source corpus.

Subfields: Clinical Psychology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/71ab15c16a5ebea862a110daac4236df6e73633c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Psychology

1. S. Leucht

In Psychiatry and Mental health

1. I. Graham
2. Marc A. F. De Hert
3. Christoph U. Correll
4. Hans-Jürgen Möller

Citations in the corpus

• Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011, background): “in SMI patients (4,5,22-27), has widened in recent decades”
• 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (2016, background): “In a Finnish cohort of patients with schizophrenia, life expectancy was about 2 decades less than in persons of similar age from the general population.(439) In patients with bipolar disorder there was a reduction in life expectancy of 12–14 years.”
• Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder (2015, background): “Furthermore, clozapine (4), antidepressants (282), and lithium (283), as well as antiepileptics (284), are associ-”